Therapeutic Perspectives in Type-1 Diabetes (SpringerBriefs in Applied Sciences and Technology)
Singh, Prachi; Kokil, Ganesh R.; Tupally, Karnaker R; Poddar, Kingshuk; Tan, Aaron; Venkatesan, Venky; Parekh, Harendra S.; Pastorin, Giorgio
Langue : anglais
Edité par Springer, 2016
- Livre broché
- Neuf

Vendeur : Ria Christie Collections, Uxbridge, Royaume-UniRia Christie Collections
Vendeur AbeBooks depuis 25 mars 2015
Etat: Neuf
EUR 59,24
Quantité disponible : Plus de 20 disponibles
Ajouter au panierItem description from seller
In English.
N° de réf. du vendeur ria9789811006012_new
- Titre
- Therapeutic Perspectives in Type-1 Diabetes (SpringerBriefs in Applied Sciences and Technology)
- Auteur
- Singh, Prachi; Kokil, Ganesh R.; Tupally, Karnaker R; Poddar, Kingshuk; Tan, Aaron; Venkatesan, Venky; Parekh, Harendra S.; Pastorin, Giorgio
- Éditeur
- Springer
- Année de publication
- 2016
- État de l'article
- New
- Reliure
- Couverture souple
- Langue
- anglais
- ISBN à 10 chiffres
- 9811006016
- ISBN à 13 chiffres
- 9789811006012
- Poids de l'article
- 257 grammes
This book provides critical insights into and appraisals of recent breakthroughs in type 1 diabetes modulation, with a particular emphasis on the potential impact of current prevention and treatment strategies. It also discusses recent successes and failures in clinical trials. Presenting an comprehensive overview of the disease, it is especially useful for newcomers in the field. It also includes illustrations, which make it easy for the reader to grasp the basic concepts involved. Furthermore, the tables include concise and easy-to-understand information on current clinical trials.
« Synopsis » peut appartenir à une autre édition de cet ouvrage.
À propos de l’auteur
Prachi Singh received her 1st MSc degree in Industrial and Pharmaceutical Sciences from ETH (Zurich) in 2010 and 2nd MSc (research) in Pharmaceutical Science and Technology from National University of Singapore in 2014, working on Dendrimers for drug delivery in type II diabetes.
During the period of 2007-2015, she held several positions such as (i) analytical R&D trainee in Novartis AG, Basel, (ii) occupational trainee at the Pharmacy Australian Centre of Excellence, University of Queensland. She is currently a Research Associate at Nanyang Technological University (Singapore) in School of Biological Science.
Her research interests focus in Drug delivery and Analytical Biochemistry. Currently she is working on a relatively new potential technology named Weak Affinity Chromatography in fragment-based screening.
Ganesh R. Kokil is currently pursuing his PhD degree at the School of Pharmacy, Pharmacy Australia Centre of Excellence, The University of Queensland, Brisbane, Australia, under the supervision of Dr. Harendra S Parekh (medicinal/formulation chemist), Dr. Rakesh N. Veedu (nucleic acid biologist) and Prof. Grant A. Ramm (liver expert). He obtained his pharmacy degree from Shivaji University, India (2004) and Master's in pharmaceutical chemistry from Bharati Vidyapeeth University, India (2007). He is a recipient of the prestigious GATE (Graduate Aptitude Test in Engineering) fellowship for Master's (2005-2007) and University of Queensland International Scholarship for pursuing his PhD studies (2012 to 2015). His areas of research interest include designing, developing, and delivering modified nucleic acid-based therapeutics against type 2 diabetes mellitus with 14 international peer-reviewed publications to his credit.
Karnaker R. Tupally is currently pursuing his PhD degree at the School of Pharmacy, Pharmacy Australia Centre of Excellence, The University of Queensland, Brisbane, Australia, under the supervision of Dr. Harendra S Parekh (medicinal/formulation chemist), Dr. Defang Ouyang (formulation/computational chemist). He obtained his pharmacy degree from Kakatiya University, India (2008) and Master's in pharmaceutical analysis & quality assurance from Jawaharlal Nehru technological university, India (2011). He is a recipient of University of Queensland International Scholarship for pursuing his PhD studies (2012 to 2015). Karnaker research involves engineering novel disulfide-contained building blocks for therapeutic applications such as bioreducible peptide dendrimers for gene/drug delivery, design and development of disulfide-bridged therapeutic peptides, molecular dynamic for carrier drug interaction and also exploring other exciting opportunities to use of stable disulfide bridges for labelling biomolecules and drug-conjugates.
Aaron Tan is a clinical medical student at University College London (UCL), in the MBBS/PhD clinician-scientist training programme. He obtained both his integrated BSc in Surgical Sciences, and his PhD in Surgery & Bioengineering from UCL. He is also concurrently a visiting scholar at the Biomaterials & Advanced Drug Delivery Laboratory (BioADD) at Stanford University. He has published in excess of 35 peer-reviewed scientific articles and has an h-index of 13. His research interests are in the field of material sciences, bioengineering, and plastic surgery.
Prof. Venkatesan has been a Physicist and manager for 17 years with Bell Labs and Bellcore and in the last 17 years has been with the Center for Superconductivity Research at University of Maryland, College Park. He founded the Surface Center at Rutgers University where he was a Professor for about five years (85-90). Most recently he was leading an effort in Oxide Electronics at UMD. Since 2008 he is directing the NanoCore Research Center at the National University of Singapore. He pioneered the Pulsed Laser deposition process and was the first to elucidate the intricacies of the process to make this a reproducible laboratory technique for the growth of high quality multi-component oxide thin films. He is an ISI highly cited Physicist (>20,000 citations ranked 66) has over 450 papers and 27 patents in the area of oxides involving superconductors, magnetic and optical materials. He is a Fellow of the American Physical society, World Innovation Forum, winner of the Bellcore award of excellence and the UMD graduate Board award. He was a member of the Physics Policy Committee and is the founding member of the International Oxide Electronics Workshop. He holds a PhD from the University of New York and Bell Laboratories, USA and an MSc and a BSc (Honors) from the Indian Institute of Technology in Kanpur, India.
His research group is one of the leading ones in the field of Oxide based Thin films. A new field "Oxide Electronics" was christened to cover these areas of research and the areas of focus include:
1. Novelmagnetic phenomena in oxides (Diluted magnetic oxides and Multiferroics)
2. Wide band gap oxides and nitrides (ZnMgO, TiO2 and AlN)
3. Superhydrogenic Dopants in Oxides
Dr Harendra (Harry) Parekh holds a PhD in Medicinal Chemistry from the University of Nottingham (UK, 2002), and is currently Senior Lecturer & Research Group leader - Drug/Gene Delivery at the Pharmacy Australia Centre of Excellence (PACE), the University of Queensland (UQ; 2005-present), Australia.
His group's research interests lie in the engineering of biocompatible and highly translatable systems for the delivery of a broad range of therapeutics to treat a number of diseases of global significance, most notably age-related macular degeneration, diabetes and cancer. Through active collaborations with a range of academic and industry partners in India, China, Singapore, Germany, Brazil and USA his team is pursuing the application of dendrimers, liposomes and bubble liposomes as wellas traditional Chinese & Indian medicine for both health and cosmetic benefit.
Giorgia Pastorin received her MSc degree in Pharmaceutical Chemistry and Technology in 2000 and her Ph.D. in 2004 from the University of Trieste (Italy), working on adenosine receptors' antagonists.
She spent 2 years as a postDoc at CNRS in Strasbourg (France) where she acquired some skills in drug delivery.
She joined the National University of Singapore in June 2006, as Assistant Professor in the Department of Pharmacy-Faculty of Science and was promoted to Associate Professor in July 2011. Since June 2014, she is Assistant Head in the same Department.She has published more than 80 manuscripts and edited 2 books on carbon nanotubes and controlled release.
« A propos de ce titre » peut appartenir à une autre édition de cet ouvrage.
Ria Christie Collections
Uxbridge, Royaume-Uni
Vendeur AbeBooks depuis 25 mars 2015
Frais d'expédition de Royaume-Uni vers Etats-Unis
| Article | 6 à 12 jours ouvrés | 6 à 12 jours ouvrés |
|---|---|---|
| Premier article | EUR 10,92 | EUR 10,92 |
Modes de paiement
Description de la boutique
Hello! Ria Christie Collections is an online venture that was initially set up in 2012 to sell books. We do not have a physical high street store. We are professional online booksellers. We only sell brand new books in perfect condition that we source from various suppliers and the publishers. Primarily, our aim is to provide an excellent service to all our customers. We always work as a team to achieve this. Our other objectives are to: 1. Ensure that all our products reach their destination quickly in a safe and secure manner 2. Answer to all our customer queries within 24 hours 3. Ensure that our customers are happy with their purchases 4. Provide all the items at a competitive price 5. Always listen to our customers Ria Christie Collections is not a registered company. It is a Sole Trader venture. Other key information is shown below: Contact Person Name: Rakesh Luchmun (Mr) Storefront Name: Ria Christie Collections Place of Establishment Address: Suite B; ARUN House; ARUN Building Arundel Road Uxbridge UB8 2RR United Kingdom E-Mail Address: riachristie@hotmail.co.uk VAT Number: GB 160 5650 25 We always work hard and aim to comply with all of Abebooks Policies. If you have any issues, please do not hesitate to write to us whether before or after a purchase. We promise to reply to you promptly and, in any case, within 24 hours. Thank you kindly! Yours sincerely Mr Rakesh Luchmun (Founder) and the Ria Christie Collections Team…
Spécialité
Educational books, Textbooks, Fiction, Non- fictionProfil professionnel du vendeur
Ryefield Investments Limited
175 Pield Heath Road
Uxbridge, Royaume-Uni UB8 3NL
Conditions de vente
All Returns and Refund are as per Abebooks policies.
Droit de rétractation
Si vous êtes un consommateur, vous pouvez exercer votre droit de rétractation sur le contrat conformément à ce qui suit. Le mot « consommateur » désigne toute personne physique agissant à des fins qui n'entrent pas dans le cadre de son activité commerciale, artisanale ou professionnelle.
Informations concernant le droit de rétractation
Droit statutaire de rétractation
Vous avez le droit d'exercer votre droit de rétractation sur ce contrat dans les 14 jours sans donner de raison.
Le délai de rétractation expirera au bout de 14 jours à compter du jour où vous-même, ou un tiers autre que le transporteur et désigné par vous, prendrez physiquement possession de la dernière marchandise, du dernier lot ou de la dernière pièce.
Pour exercer votre droit de rétractation, remplissez électroniquement et envoyez une déclaration claire sur notre site Web, sous « Vos achats » dans « Votre compte ». Nous vous communiquerons sans délai un accusé de réception de cette rétractation sur un support durable (par exemple, par e-mail).
Pour respecter le délai de rétractation, il vous suffit d'envoyer votre message concernant l'exercice de votre droit de rétractation avant l'expiration du délai de rétractation.
Effets de la rétractation
Si vous exercez votre droit de rétractation sur ce contrat, nous vous rembourserons tous les paiements que vous avez effectués, y compris les frais de livraison (à l'exception des frais supplémentaires résultant du choix d'un mode de livraison autre que le type de livraison standard le moins cher que nous proposons).
Nous pouvons déduire du remboursement la perte de valeur de toute marchandise livrée, si la perte est le résultat d'une manipulation inutile de votre part.
Nous effectuerons le remboursement dans les meilleurs délais, et au plus tard 14 jours après le jour où nous aurons été informés de votre décision d'exercer votre droit de rétractation sur ce contrat.
Nous effectuerons le remboursement en utilisant le même moyen de paiement que celui que vous avez utilisé pour la transaction initiale, sauf si vous en avez expressément convenu autrement ; en tout état de cause, aucuns frais ne vous seront facturés à la suite d'un tel remboursement.
Nous pouvons suspendre le remboursement jusqu'à ce que nous ayons reçu les marchandises ou que vous ayez fourni la preuve que vous avez renvoyé les marchandises, en fonction de la première éventualité.
Vous devez renvoyer les marchandises ou les remettre à Ria Christie Collections, Uxbridge, United Kingdom, sans retard injustifié et, en tout état de cause, au plus tard 14 jours à compter du jour où vous nous avez communiqué votre décision de rétractation du présent contrat. Le délai est respecté si vous renvoyez les marchandises avant l'expiration du délai de 14 jours. Vous devrez prendre en charge les frais directs du renvoi des marchandises. Vous n'êtes responsable que de toute diminution de valeur des marchandises résultant d'une manipulation autre que celle nécessaire pour établir la nature, les caractéristiques et le fonctionnement des marchandises.
Exceptions au droit de rétractation
Le droit de rétractation ne s'applique pas à ce qui suit :
- Distribution de journaux, de revues ou de magazines, à l'exception des contrats d'abonnement ; et
- Fourniture d'un contenu numérique qui n'est pas fourni sur un support matériel (par exemple, sur un CD ou un DVD) si vous avez accepté, lors de votre commande, que nous puissions commencer à le livrer et que vous ne puissiez pas exercer votre droit de rétractation une fois la livraison commencée.
Conditions d'expédition
Orders usually ship within 2 business days. If your book order is heavy or oversized, we may contact you to let you know extra shipping is required. Thank you!